which glp 1 medication has the least side effects what glp 1 has least side effects Comparing Ozempic, Wegovy and Other

Given the study did not show a significant difference in fibrosis stage, semaglutide has not yet been FDA approved for NASH

Also, patients on tirzepatide were less likely to progress to a worse UACR stage (HR 0.43, 95% CI 0.270.71) and more likely to regress to a less severe UACR stage (HR 1.97, 95% CI 1.512.57) compared to insulin glargine [49]

Silveira SQ, Da Silva LM, De Campos Vieira Abib A, et al

Among the 27% who reported it, 71% said the problem resolved or significantly improved with dose timing changes, underscoring that this is a manageable side effect rather than a reason to stop treatment

Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis